AcelRx Pharmaceuticals Inc. (NASDAQ:ACRX) went down by -1.40% during the previous trading session, and it is maintaining the win ahead of Wednesday’s trading session. The share price of the Drug Manufacturers – Specialty & Generic giant went up by $1.41 to trade ended Wednesday trading at $1.43. This is down from the $1.43 price recorded on Tuesday’s trading session. Its performance from the start of the year has also been negative, with ACRX down by -33.18% year-to-date.
AcelRx Pharmaceuticals Inc. (ACRX) started the day trading at $1.44 and recorded an intraday high of $1.48. It also recorded an intraday low of $1.36 during Wednesday’s trading session. AcelRx Pharmaceuticals Inc. is a very active stock that recorded a trading volume that is more than 24.26% of the average daily trading volume on Wednesday. The stock’s trading volume on Wednesday was 1544727, which is more than 24.26 of the total average daily trading volume of 1.17 million.
AcelRx Pharmaceuticals Inc. (NASDAQ:ACRX) 2020 Performance Impressive
The increase in ACRX’s stock price on Wednesday saw its overall performance boost over the past few months. We can quantify the performance of the stock so far this year using a few metrics. The 52-week high price of ACRX currently stands at $3.02, which is higher than the current trading price of the stock by 53.31%. However, ACRX’s current trading price is -101.43% lower than the 52-week low price of $0.70. In terms of trading volume, AcelRx Pharmaceuticals Inc. currently experienced healthy participation during the last trading session. 1544727 shares of AcelRx Pharmaceuticals Inc. were traded on the stock exchange on Wednesday, which is more than 24.26% of the 1.17 million average trading volume of the stock.
The performance of the stock has been positive over the past year. ACRX’s performance over the past one year has seen it plunge by -41.74%, while the stock has gone down by -38.16% in the last six months. The quarterly performance of ACRX currently stands at 69.33%, and it is down by -1.40% in the last month. The only positive figure was from the weekly performance, which currently reads 2.17%. At the time of writing ACRX’s report, the company has a total market cap of $111.28M, making it one of the largest publicly-traded companies in the world.AcelRx Pharmaceuticals Inc. also has over 73 employees all over the world.
ACRX Insider Activities
For AcelRx Pharmaceuticals Inc., insiders hold 23.90% of all company shares. The insider transactions over the past six months are down by 0.00%. During that period, insiders bought 545,047 shares in 7 transactions. In that same period, insiders sold 150,126 of their shares in 6 transactions. After these transactions, insiders at AcelRx Pharmaceuticals Inc. now hold 1.51M shares, which is over 24.01% of the total company stocks. Institutional investors currently hold a large chunk of the ACRX shares, as they control 1.87% of the company’s total stock.
ACRX Fundamental Analysis
For AcelRx Pharmaceuticals Inc., the stock’s diluted earnings per share (EPS) stands at -0.70. In the coming year, analysts expect the EPS to be -0.22. The stock’s EPS growth this year is 16.70%, 2.60% in the previous five years. In terms of revenue, AcelRx Pharmaceuticals Inc.’s quarterly sales (YOY) is shrinking at -0.15, which is lower than the average annual revenue of 2.60% over the past half a decade.
The Return on Investment (ROI) on AcelRx Pharmaceuticals Inc.’s stock currently stands at 340.90%.
ACRX Analysts Prediction
In November 11, 2019, several analysts reiterated their positions on the AcelRx Pharmaceuticals Inc. stock and predicted its performance to their investors. The analysts at Credit Suisse believe ACRX is still a Neutral and set the price target between $7 and $2.
B. Riley FBR and Jefferies also believe that AcelRx Pharmaceuticals Inc.’s stock is outperforming at the moment. ACRX received a positive rating from RBC Capital Mkts, which set a price target of $6-$5 for the stock.
ACRX Technical Analysis
The Simple Moving Average (SMA) is one of the most powerful technical indicators. The 20-day Simple Moving Average of ACRX currently stands at -0.39%, while the SMA50 is -1.27%. The biggest one is the SMA200, which is currently reading -19.55% ahead of Wednesday’s trading session. The Relative Strength Index of this stock is 49.96.